Drug application
THRIVE (NICOTINE POLACRILEX)
Drugs@FDA ANDA 077656 · GLAXOSMITHKLINE CONS
Key facts
| Drug name | THRIVE |
|---|---|
| Active ingredients | NICOTINE POLACRILEX |
| Application type | ANDA |
| Application number | 077656 |
| Company | GLAXOSMITHKLINE CONS |
| Dosage forms | GUM, CHEWING, BUCCAL |
| Strength | EQ 4MG BASE |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission status date | Jun 19, 2007 |
At a glance
- 1–9 Submissions
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.